Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. The firm provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. The company operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India, and others.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Revenue
2,158
2,021
1,742
1,581
1,681
1,971
Revenue Growth (YoY)
14%
16%
10%
-6%
-15%
56%
Cost of Revenue
790
750
698
642
629
725
Gross Profit
1,367
1,270
1,044
938
1,052
1,245
Selling, General & Admin
559
534
492
431
393
396
Research & Development
230
226
198
174
154
136
Operating Expenses
790
761
691
606
547
533
Other Non Operating Income (Expenses)
--
--
--
--
--
--
Pretax Income
580
503
235
328
504
718
Income Tax Expense
143
126
103
77
127
194
Net Income
437
377
132
250
376
524
Net Income Growth
146%
186%
-47%
-34%
-28%
83%
Shares Outstanding (Diluted)
591.22
590.19
586.17
581.63
579.99
579.58
Shares Change (YoY)
0%
1%
1%
0%
0%
0%
EPS (Diluted)
0.73
0.63
0.22
0.43
0.64
0.9
EPS Growth
144%
183%
-47%
-34%
-28%
82%
Free Cash Flow
451
445
90
26
154
440
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
63.34%
62.84%
59.93%
59.32%
62.58%
63.16%
Operating Margin
26.73%
25.18%
20.26%
20.99%
30.04%
36.12%
Profit Margin
20.25%
18.65%
7.57%
15.81%
22.36%
26.58%
Free Cash Flow Margin
20.89%
22.01%
5.16%
1.64%
9.16%
22.32%
EBITDA
--
--
--
--
--
--
EBITDA Margin
--
--
--
--
--
--
D&A For EBITDA
--
--
--
--
--
--
EBIT
577
509
353
332
505
712
EBIT Margin
26.73%
25.18%
20.26%
20.99%
30.04%
36.12%
Effective Tax Rate
24.65%
25.04%
43.82%
23.47%
25.19%
27.01%
Follow-Up Questions
What are Fisher & Paykel Healthcare Corporation Limited's key financial statements?
According to the latest financial statement (Form-10K), Fisher & Paykel Healthcare Corporation Limited has a total asset of $2,550, Net profit of $377
What are the key financial ratios for FSPKF?
Fisher & Paykel Healthcare Corporation Limited's Current ratio is 3.86, has a Net margin is 18.65, sales per share of $3.42.
How is Fisher & Paykel Healthcare Corporation Limited's revenue broken down by segment or geography?
Fisher & Paykel Healthcare Corporation Limited largest revenue segment is Hospital, at a revenue of 1,280,300,000 in the most earnings release.For geography, North America is the primary market for Fisher & Paykel Healthcare Corporation Limited, at a revenue of 967,200,000.
Is Fisher & Paykel Healthcare Corporation Limited profitable?
yes, according to the latest financial statements, Fisher & Paykel Healthcare Corporation Limited has a net profit of $377
Does Fisher & Paykel Healthcare Corporation Limited have any liabilities?
yes, Fisher & Paykel Healthcare Corporation Limited has liability of 660
How many outstanding shares for Fisher & Paykel Healthcare Corporation Limited?
Fisher & Paykel Healthcare Corporation Limited has a total outstanding shares of 585.9